ACRX AcelRx Pharmaceuticals Inc.

2.42
+0.01  (+1%)
Previous Close 2.41
Open 2.42
Price To Book -24.23
Market Cap 191,216,925
Shares 78,914,170
Volume 16,475
Short Ratio
Av. Daily Volume 1,465,344

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released August 15 2016
ARX-04 (SAP302)
Patients who presented to emergency departments with moderate-to-severe acute pain associated with trauma or injury
FDA Approval announced November 2, 2018.
DSUVIA (ARX-04)
Moderate-to-severe acute pain following a surgical procedure
CRL Jul 26 2014. NDA resubmission timing to be known in 2H 2019.
Zalviso
Post-operative pain following open abdominal surgery and hip or knee replacement surgery

Latest News

  1. Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I
  2. Edited Transcript of ACRX earnings conference call or presentation 8-May-19 8:30pm GMT
  3. AcelRx announces the closing of a $25 million senior secured debt facility
  4. AcelRx Pharmaceuticals (ACRX) Upgraded to Buy: Here's Why
  5. AcelRx Pharmaceuticals Inc (ACRX) Q1 2019 Earnings Call Transcript
  6. Here's Why AcelRx Pharmaceuticals Fell as Much as 14% Today
  7. AcelRx Pharmaceuticals (ACRX) Reports Q1 Loss, Lags Revenue Estimates
  8. AcelRx Pharmaceuticals: 1Q Earnings Snapshot
  9. AcelRx Pharmaceuticals, Inc. to Host Earnings Call
  10. What's in the Cards for AcelRx (ACRX) This Earnings Season?
  11. Will AcelRx Pharmaceuticals (ACRX) Report Negative Earnings Next Week? What You Should Know
  12. 3 Stocks Peter Lynch Would Love
  13. AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019
  14. AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th Annual Regional Anesthesiology & Acute Pain Medicine Meeting
  15. Edited Transcript of ACRX earnings conference call or presentation 7-Mar-19 9:30pm GMT
  16. Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy
  17. AcelRx Pharmaceuticals (ACRX) Upgraded to Buy: What Does It Mean for the Stock?
  18. AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference
  19. Why AcelRx Pharmaceuticals Stock Is Sinking Today